Becker's Healthcare November 18, 2024
Rylee Wilson

The Drug Enforcement Administration will extend rules allowing providers to prescribe controlled substances via telehealth through the end of 2025.

In a news release published Nov. 15, the agency says it is “continuing to consider” feedback it received on telehealth prescribing rules and is working toward a final rule.

During the COVID-19 pandemic, the DEA implemented several telehealth flexibilities, including allowing prescribing of controlled substances. Before the pandemic, patients were required to have at least one in-person visit with a provider before they could receive controlled substances via telehealth.

Here are three things for behavioral health leaders to note:

  1. Proponents of the policy argue telehealth increases access to medication-assisted treatment for opioid use disorder treatment...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Mental Health, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Health care package winners and losers
Wisp Teams Up with Nourish to Combine GLP-1s with Nutrition Counseling
Temporary Federal Funding Bill Addresses SUPPORT Act Reauthorization, Ghost Networks and Telehealth Flexibilities
Stopgap funding bill includes sweeping PBM reform, preserves telehealth flexibilities

Share This Article